US EditionSeQuent–Viyash merger receives stock exchange approvals; NCLT filing underway - Express Pharma
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
SeQuent–Viyash merger receives stock exchange approvals; NCLT filing underway - Express Pharma
Sequent Scientific, a player in the global animal health industry, has announced that it has secured approvals from both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) for its proposed merger with Hyderabad-based Viyash Life Sciences. The company has now filed for clearance with the National Company Law Tribunal (NCLT). The merger will bring together two business verticals—Global Animal Health and an integrated API busines…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
